Abstract |
Ethanolamine plasmalogen (pPE), a major phospholipid in neuronal membranes, is specifically reduced in postmortem brains from patients with Alzheimer's disease (AD). The purpose of the present study was to compare the effects of EPA-enriched ethanolamine plasmalogen (EPA-pPE) and EPA-enriched phosphatidylethanolamine (EPA-PE) on cognitive deficiency and illustrate the possible underlying mechanisms. SD rats were divided into four groups including the sham group injected with 0.9% saline and three amyloid-β (Aβ) infusion groups, Aβ42 group, EPA-pPE group and EPA-PE group. EPA-pPE and EPA-PE were administered by gavage (150 mg kg-1 day-1), respectively, once a day for 26 days. Administration of EPA-pPE exerted better effects than EPA-PE in improving Aβ-induced cognitive deficiency in a rat model of Alzheimer's disease. Further mechanical research indicated that EPA-pPE was superior to EPA-PE in regulating oxidative stress via increasing SOD activity and decreasing MDA level, as well as reducing GSK-3β and tau phosphorylation. Moreover, EPA-PE was more effective than EPA-pPE at inhibiting the protein expressions of Bax and caspase 9. The results of neuro- inflammation and inflammasome activation showed that EPA-pPE exerted more significant effects than EPA-PE in inhibiting the expressions of TNF-α and IL-1β, and decreasing NLRP3, pro-caspase 1 and caspase 1 levels. EPA-pPE alleviated Aβ-induced neurotoxicity by inhibiting oxidative stress, neuronal injury, apoptosis and neuro- inflammation, which might depend on the vinyl ether linkage at the sn-1 position.
|
Authors | Hongxia Che , Qian Li , Tiantian Zhang , Lin Ding , Lingyu Zhang , Haohao Shi , Teruyoshi Yanagita , Changhu Xue , Yaoguang Chang , Yuming Wang |
Journal | Food & function
(Food Funct)
Vol. 9
Issue 5
Pg. 3008-3017
(May 23 2018)
ISSN: 2042-650X [Electronic] England |
PMID | 29774334
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Amyloid beta-Peptides
- Interleukin-1beta
- Phosphatidylethanolamines
- Plasmalogens
- phosphatidal ethanolamines
- phosphatidylethanolamine
- Eicosapentaenoic Acid
- Glycogen Synthase Kinase 3 beta
|
Topics |
- Alzheimer Disease
(drug therapy, genetics, metabolism, psychology)
- Amyloid beta-Peptides
(genetics, metabolism, toxicity)
- Animals
- Apoptosis
(drug effects)
- Cognition
(drug effects)
- Eicosapentaenoic Acid
(administration & dosage)
- Glycogen Synthase Kinase 3 beta
(genetics, metabolism)
- Humans
- Interleukin-1beta
(genetics, metabolism)
- Male
- Oxidative Stress
(drug effects)
- Phosphatidylethanolamines
(administration & dosage)
- Plasmalogens
(administration & dosage)
- Rats
- Rats, Sprague-Dawley
|